# A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study

> **NCT02205476** · PHASE2 · TERMINATED · sponsor: **Pfizer** · enrollment: 10 (actual)

## Conditions studied

- Hypertrophic Scars Resulting From Prior Breast Scar Revision Surgery

## Interventions

- **DRUG:** PF-06473871
- **DRUG:** PF-06473871

## Key facts

- **NCT ID:** NCT02205476
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-12
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** B5301001 study did not meet its predefined efficacy endpoints, the long term follow up study B5301012 was terminated in 1/6/2015. No safety concerns identified.
- **Last updated:** 2016-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02205476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02205476, "A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02205476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*